FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Schwab

Research Profile

Chemicals & Drugs

Living Beings

Mouse

Disorders

Physiology

Mutation

Procedures

Devices

Enteral Nutrition

Co-author Network

Publications

TOP 3
Miguel Tejeda; D Gaal; Lehel Hullán; Orsolya Csuka; Richard Schwab; O Szokoloczi; G Y Kéri
Continuous administration of the somatostatin structural derivative /TT-232/ by subcutaneously implanted osmotic pump improves the efficacy and potency of antitumor therapy in different mouse and human tumor models.
Ferenc Pinter; Judit Pápay; Andrea Almasi; Zoltan Sapi; Edit Szabo; Melinda Kanya; Anna Tamasi; Balazs Jori; Edit Varkondi; Judit Moldvay; Klára Szondy; György Keri; Massimo Dominici; Pierfranco Conte; Sandor Eckhardt; László Kopper; Richard Schwab; István Peták
Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.
Edit Varkondi; Ferenc Pinter; Kiss Robert; Richard Schwab; Nora Breza; László Õrfi; György Keri; István Peták
Biochemical assay-based selectivity profiling of clinically relevant kinase inhibitors on mutant forms of EGF receptor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Schwab (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Miguel Tejeda; D Gaal; Lehel Hullán; Orsolya Csuka; Richard Schwab; O Szokoloczi; G Y Kéri
Continuous administration of the somatostatin structural derivative /TT-232/ by subcutaneously implanted osmotic pump improves the efficacy and potency of antitumor therapy in different mouse and human tumor models.
Anticancer research 2008;28(5A):2769-74.
2008: Ferenc Pinter; Judit Pápay; Andrea Almasi; Zoltan Sapi; Edit Szabo; Melinda Kanya; Anna Tamasi; Balazs Jori; Edit Varkondi; Judit Moldvay; Klára Szondy; György Keri; Massimo Dominici; Pierfranco Conte; Sandor Eckhardt; László Kopper; Richard Schwab; István Peták
Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.
The Journal of molecular diagnostics : JMD 2008;10(2):160-8.
2008: Edit Varkondi; Ferenc Pinter; Kiss Robert; Richard Schwab; Nora Breza; László Õrfi; György Keri; István Peták
Biochemical assay-based selectivity profiling of clinically relevant kinase inhibitors on mutant forms of EGF receptor.
Journal of receptor and signal transduction research 2008;28(3):295-306.
2007: Miguel Tejeda; Dezsõ Gaál; Lehel Hullán; Richard Schwab; O Szokoloczi; György Kéri
Antitumor activity of the somatostatin structural derivative (TT-232), against mouse and human melanoma tumor models.
Anticancer research 2007;27(6B):4015-9.
2007: Richard Schwab; Tamás Micsik; Orsolya Szokolóczi; Eszter Schafer; Balázs Tihanyi; Tibor Tihanyi; Péter Kupcsulik; Katalin Diófalvi; Tamás Mersich; Istvan Besznyak; Attila Zaránd; Rudolf Mihalik; Balázs Sarkadi; György Kéri; Akos Pap; Ferenc Jakab; László Kopper; István Peták
Functional evaluation of multidrug resistance transporter activity in surgical samples of solid tumors.
Assay and drug development technologies 2007;5(4):541-50.
2007: Simon Fischer; Péter Lakatos; Laszlo Lakatos; Agota Kovacs; Tamas Molnar; István Altorjay; Mária Papp; Aniko Szilvasi; Zsolt Tulassay; Janos Osztovits; Janos Papp; Pal Demeter; Richard Schwab; Attila Tordai; Hajnalka Andrikovics
ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases.
Scandinavian journal of gastroenterology 2007;42(6):726-33.
2006: Miguel Tejeda; Dezsõ Gaál; L Hullán; Orsolya Csuka; Richard Schwab; O Szokoloczi; György Kéri
A comparison of the tumor growth inhibitory effect of intermittent and continuous administration of the somatostatin structural derivative TT-232 in various human tumor models.
Anticancer research 2006;26(4B):3011-5.
2005: Richard Schwab; István Peták; Ferenc Pintér; Edit Szabó; Melinda Kánya; Anna Tamási; Edit Várkondi; Andrea Almási; Orsolya Szokolóczi; Judit Pápay; Judit Moldvay; György Kéri; László Kopper
[Epidermal growth factor receptor (EGFR): therapeutic target in the treatment of lung adenocarcinoma].
Orvosi hetilap 2005;146(46):2335-42.
2005: Richard Schwab; Ferenc Pinter; Judit Moldavy; Judit Pápay; Janos Strausz; László Kopper; György Keri; Akos Pap; István Peták; Karoly Oreskovich; Laszlo Mangel
Modern treatment of lung cancer: case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7736-8.
2005: Györgyi Fodor; Richard Schwab; Tibor Gyökeres; Akos Pap
[Electrogastrography monitoring of the effectiveness of prokinetic and cognitive therapy in functional dyspepsia].
Orvosi hetilap 2005;146(26):1393-7.
2005: Martin Sukopp; Richard Schwab; Luciana Marinelli; Eric Biron; Markus Heller; Edit Várkondi; Akos Pap; Ettore Novellino; György Kéri; Horst Kessler
Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Journal of medicinal chemistry 2005;48(8):2916-26.
2005: Orsolya Szokolóczi; Richard Schwab; István Peták; László Õrfi; Akos Pap; Alex N. Eberle; Tamás Szüts; György Kéril
TT232, a novel signal transduction inhibitory compound in the therapy of cancer and inflammatory diseases.
Journal of receptor and signal transduction research 2005;25(4-6):217-35.
2005: Edit Varkondi; Eszter Schäfer; Gyöngyi Bökönyi; Tibor Gyökeres; László Õrfi; István Peták; Akos Pap; Orsolya Szokoloczi; György Keri; Richard Schwab
Comparison of ELISA-based tyrosine kinase assays for screening EGFR inhibitors.
Journal of receptor and signal transduction research 2005;25(1):45-56.
2003: György Kéri; G Racz; Kálmán Magyar; László Õrfi; A Horváth; Richard Schwab; B B Hegymegi; Béla Szende
Pro-apoptotic and anti-apoptotic molecules affecting pathways of signal transduction.
Annals of the New York Academy of Sciences 2003;1010():109-12.
2003: Tibor Gyökeres; Richard Schwab; Akos Pap
Endoscopic cystenterostomy of non-bulging pancreatic fluid collections without EUS: do we really need a communication between the cyst and the duct?
Gastrointestinal endoscopy 2003;57(6):807-8; author reply 808.
2003: Miguel Tejeda; Dezsõ Gaál; Orsolya Csuka; Axel Ullrich; Richard Schwab; Akos Pap; Anikó Horváth; György Kéri
The antitumour effect of the somatostatin analogue TT-232 depends on the treatment regimen.
Cancer detection and prevention 2003;27(2):155-62.
2003: Tibor Gyökeres; J Duhl; M Varsányi; Richard Schwab; Mária Burai; Akos Pap
Double guide wire placement for endoscopic pancreaticobiliary procedures.
Endoscopy 2003;35(1):95-6.
2002: Tibor Gyökeres; Richard Schwab; Mária Burai; K Bor; Akos Pap
Duodenal duplication cyst.
Endoscopy 2002;34(6):503-4; author reply 505.
2002: Tibor Gyökeres; Richard Schwab; Mária Burai; Róbert Petrik; Ferenc Páczelt; Akos Pap
[Extracorporeal shock wave lithotripsy of pancreatic stones as a part of complex endoscopic therapy].
Orvosi hetilap 2002;143(17):881-5.
2001: Jozsef Hamvas; Richard Schwab; Akos Pap
Jejunal feeding in chronic pancreatitis with severe necrosis.
JOP : Journal of the pancreas 2001;2(3):112-6.
1999: Jozsef Hamvas; Richard Schwab; Akos Pap
Jejunal feeding in necrotising acute pancreatitis--a retrospective study.
Acta chirurgica Hungarica 1999;38(2):177-85.
1997: József Pozsár; Richard Schwab; Károly Simon; László Fekete; György Orgován; Akos Pap
Effect of endotoxin administration on the severity of acute pancreatitis in two experimental models.
International journal of pancreatology : official journal of the International Association of Pancreatology 1997;22(1):31-7.